
Peptides
Subcategories of "Peptides"
Found 29799 products of "Peptides"
ARPP-21 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARPP-21 antibody, catalog no. 70R-2326
Purity:Min. 95%DENND2C Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DENND2C antibody, catalog no. 70R-3785
Purity:Min. 95%GRAMD2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GRAMD2 antibody, catalog no. 70R-6309
Purity:Min. 95%FNDC4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FNDC4 antibody, catalog no. 70R-6597
Purity:Min. 95%ATIC Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ATIC antibody, catalog no. 70R-1295
Purity:Min. 95%H-LIAHNQVRQV-OH
HER-2/neu protein:
HER-2/neu (85-94) is an epitope from the extracellular region of Human Epidermal Growth Factor Receptor-2, receptor tyrosine kinase, also known as CD340, ERBB2 and proto-oncogene Neu. HER-2/neu contains a binding domain for HLA-A*02:01 molecule. It has been demonstrated that the over-expression of HER-2/neu plays an important role in the development and progression in primary breast cancer but also in ovarian colorectal and pancreatic adenocarcinoma. HER-2/neu has become an important biomarker and target of therapy for 30% of breast cancer patients.
Applications of HER-2/neu (85-94):
HER-2/neu (85-94) has shown its capacity to induce both cellular and humoral immune response in vivo. HER-2/neu (85-94) is used to analyze specific cytotoxic CD8 T cells responses, it has been demonstrated by ELISPOT analyses that the stimulation of cytotoxic T cells in PBMCs by HER-2/neu (85-94) produce IFN-γ against cancer cell expressing HLA-A*02:01 molecules and HER-2/neu.
It has been also demonstrated that HER-2/neu (85-94) is the single peptide of HER-2/neu which involve an increase frequency of cytotoxic CD8 T cells in the peripheral blood of breast cancer patients. HER-2/neu (85-94) is also used for vaccine development to treat diagenous rat from allied ALC cancer cells co-expressing HLA-A*02:01 and HER-2/neu.GABRB1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GABRB1 antibody, catalog no. 20R-1330
Purity:Min. 95%ASNA1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ASNA1 antibody, catalog no. 70R-10011
Purity:Min. 95%CRMP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CRMP1 antibody, catalog no. 70R-5249
Purity:Min. 95%PIP4K2A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PIP4K2A antibody, catalog no. 70R-2708
Purity:Min. 95%IFN Alpha 7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IFNA7 antibody, catalog no. 70R-5430
Purity:Min. 95%C19ORF54 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C19orf54 antibody, catalog no. 70R-3576
Purity:Min. 95%SLC39A10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC39A10 antibody, catalog no. 70R-6257
Purity:Min. 95%ACD Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACD antibody, catalog no. 70R-3020
Purity:Min. 95%GPX3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GPX3 antibody, catalog no. 70R-5305
Purity:Min. 95%WRNIP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of WRNIP1 antibody, catalog no. 70R-5646
Purity:Min. 95%FAM83B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FAM83B antibody, catalog no. 70R-3283
Purity:Min. 95%FGG Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FGG antibody, catalog no. 70R-7144
Purity:Min. 95%Carbonyl Reductase 1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CBR1 antibody, catalog no. 70R-1026
Purity:Min. 95%EXOSC7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EXOSC7 antibody, catalog no. 70R-4747
Purity:Min. 95%
